K
Karel Cool
Researcher at INSEAD
Publications - 38
Citations - 11588
Karel Cool is an academic researcher from INSEAD. The author has contributed to research in topics: Competitive advantage & Market share. The author has an hindex of 20, co-authored 38 publications receiving 11231 citations. Previous affiliations of Karel Cool include University of Antwerp.
Papers
More filters
Journal ArticleDOI
Asset stock accumulation and sustainability of competitive advantage
Ingemar Dierickx,Karel Cool +1 more
TL;DR: Barney as mentioned in this paper showed that the sustainability of a firm's asset position depends on how easily assets can be substituted or imitated, and that imitability is linked to the characteristics of the asset accumulation process: time compression diseconomies, asset mass efficiencies, interconnectedness, asset erosion and causal ambiguity.
Journal ArticleDOI
Asset Stock Accumulation and the Sustainability of Competitive Advantage: Reply
Ingemar Dierickx,Karel Cool +1 more
TL;DR: Dierickx et al. as mentioned in this paper presented a paper on asset stock accumulation and the sustainability of competitive advantage in the context of finance and finance management, which was published in 1989.
Journal ArticleDOI
Strategic Group Formation and Performance: The Case of the U.S. Pharmaceutical Industry, 1963-1982
Karel Cool,Dan Schendel +1 more
TL;DR: In this paper, a statistical procedure is proposed to longitudinally identify strategic groups and a dynamic model of competitive repositioning is proposed which helps integrate the findings from the study.
Journal ArticleDOI
Performance differences among strategic group members
Karel Cool,Dan Schendel +1 more
TL;DR: Whether and why members of the same strategic group would experience different performance results has received little attention in previous research, and a theory is developed as to how historical differences among strategic group members may result in performance differences.
Journal ArticleDOI
Rivalry, Strategic Groups and Firm Profitability
Karel Cool,Ingemar Dierickx +1 more
TL;DR: In this paper, an analysis of the U.S. pharmaceutical industry during the period 1963-82 finds that a substantial decline in industry profitability is not explained by changes in the number and size distribution of firms, in segment interdependence and in strategic distance.